Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | 0 | N/A | N/A | N/A |
2024-05-15 | 2024-03 | 0 | -0.52 | N/A | N/A |
2024-02-14 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -1.48 | N/A | N/A |
2023-09-27 | 2023-06 | 0 | 0.16 | N/A | N/A |
2023-05-11 | 2023-03 | 0 | -1.93 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | Maxim Group | Upgrade | Buy | |
2023-05-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-04-15 | CANTRELL GARY V. | Director | 204.09K | Stock Award(Grant) |
2023-06-13 | DISBROW JOSHUA R. | Chief Executive Officer | 71.59K | Purchase |
2023-08-10 | DOCKERY CARL C | Director | 8.94K | Stock Award(Grant) |
2021-04-07 | HECHT BETH P | Director | 9.05K | Stock Award(Grant) |
2023-08-15 | JAIN ABHINAV | Director | 8.00K | Stock Award(Grant) |
2023-08-10 | LIU VIVIAN H | Director | 1.84K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Nantahala Capital Management, LLC | 1.09M | 1.74M | 19.65% |
2023-06-29 | Stonepine Capital Management, LLC | 472.37K | 755.79K | 8.54% |
2023-06-29 | Renaissance Technologies, LLC | 57.32K | 91.72K | 1.04% |
2023-06-29 | Blackrock Inc. | 24.06K | 38.49K | 0.44% |
2023-06-29 | Acadian Asset Management. LLC | 22.54K | 36.06K | 0.41% |
2023-06-29 | Prudential Financial, Inc. | 19.58K | 31.32K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 9.99K | 15.99K | 0.18% |
2023-05-30 | Fidelity Extended Market Index Fund | 8.71K | 14.55K | 0.16% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.59K | 2.66K | 0.03% |
2023-05-30 | Fidelity Total Market Index Fund | 1.59K | 2.65K | 0.03% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 1.27K | 2.15K | 0.02% |
Split | Date |
---|---|
1 : 20 | 2023-01-06 |
1 : 10 | 2020-12-09 |
1 : 20 | 2018-08-13 |
1 : 20 | 2017-08-29 |
1 : 12 | 2016-07-01 |
82 : 1000 | 2015-06-10 |
-
I want to protest... tomorrow is not my Friday and it is for some people. Not fair. Guess I will just have to get rich off these guys so I can retire... rough life. Cheers. AYTU
-
Merger with Neos is huge = 100 million annual sales. I just keep adding down here.
-
-
-
-
All of you with high averages !!!! Wait for it. You will get ur money back out. This company is being made to sell. That main reason for them getting retail investors out. Recognize the game for future big boy stocks. This is how they drag u through the mud for years plus. Imo I see triple digits for buyout from big pharm when Healight is more legit. 1-3 billion price tag minimum. U do the math.
-
Bet we get bought out for $120+. Who will hold for gold ???
-
Yes trump is guilty of murder on capital hill like the Dems are guilty for burning down America last four years lol
-
$AYTU
What is the current share count for josh? -
$AYTU Sabby is finally realizing the potential!!
What is the meaning of passive investment?
Also known as a buy-and-hold strategy, passive investing means buying a security to own it long-term. Unlike active traders, passive investors do not seek to profit from short-term price fluctuations or market timing. -
Sabby jumped in watch em run it up. They are used to control price action both ways up and down. We did down already, so let us go up now !!!
-
People sabby gets brought in to control price action, both ways
-
All the news saying we drop soon. Means I am Grabbing more this week !!!
-
No action for year. But I believe will sell this company for 3-5 billion dollars. 30-50x current market value
-
So, what are the facts: PR about termination of the study. No results, yet. Submission has been announced with no guarrantee that it is gonna be "fast track". If it is a case it will take 6 months during which Josh will dilute and fill up his pockets. Did I miss anything?
-
-
-
-
-
-
Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
accesswire.com • -
Best Penny Stocks? 4 Hot Stocks With News This Week
pennystocks.com • -
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
seekingalpha.com •